Amrize (NYSE:AMRZ) Given New $46.00 Price Target at UBS Group

Amrize (NYSE:AMRZ – Get Free Report) had its target price upped by investment analysts at UBS Group from $42.00 to $46.00 in a report released on Monday, Marketbeat.com reports. The brokerage currently has a “hold” rating on the stock. UBS Group‘s price objective would suggest a potential upside of 15.47% from the company’s current price.

Several other equities analysts have also recently weighed in on AMRZ. William Blair set a $40.00 price target on Amrize in a research report on Wednesday, September 2nd. Berenberg Bank downgraded Amrize from a “buy” rating to a “hold” rating and cut their target price for the stock from $48.00 to $46.00 in a research note on Monday, November 9th. Oppenheimer cut their target price on Amrize from $55.00 to $52.00 and set an “outperform” rating for the company in a research note on Monday, November 2nd. Wells Fargo & Company reduced their target price on Amrize from $40.00 to $39.00 and set an “equal weight” rating for the company in a report on Friday, October 30th. Finally, Sanford C. Bernstein reaffirmed an “outperform” rating and set a $60.00 target price on shares of Amrize in a report on Monday, September 21st. Eight equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and five have given a Sell rating to the company. According to data from MarketBeat.com, Amrize has a consensus rating of “Hold” and a consensus price target of $47.18.

Check Out Our Latest Analysis on Amrize

Amrize Stock Down 1.7%

Amrize stock opened at $39.84 on Monday. Amrize has a 1-year low of $35.78 and a 1-year high of $65.94. The firm has a market capitalization of $22.03 billion, a price-to-earnings ratio of 18.03, a P/E/G ratio of 1.59 and a beta of 0.04. The company has a current ratio of 1.07, a quick ratio of 0.67 and a debt-to-equity ratio of 0.33. The firm has a 50 day simple moving average of $39.22 and a 200 day simple moving average of $49.85.

Amrize (NYSE:AMRZ – Get Free Report) last issued its earnings results on Wednesday, October 28th. The company reported $1.05 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $1.05. The business had revenue of $3.77 billion for the quarter. Amrize had a net margin of 9.93% and a return on equity of 10.02%. The company’s revenue was up 2.6% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.98 EPS. On average, analysts predict that Amrize will post 2.30 earnings per share for the current year.

Insider Activity at Amrize

In related news, Director Jacques Sanche purchased 4,150 shares of the firm’s stock in a transaction on Wednesday, August 26th. The shares were acquired at an average cost of $45.02 per share, with a total value of $186,833.00. Following the purchase, the director directly owned 9,766 shares of the company’s stock, valued at approximately $439,665.32. This trade represents a 73.90% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO Jan Jenisch acquired 26,000 shares of the stock in a transaction on Wednesday, September 2nd. The stock was bought at an average price of $42.47 per share, with a total value of $1,104,220.00. Following the transaction, the chief executive officer directly owned 1,767,000 shares of the company’s stock, valued at approximately $75,044,490. The trade was a 1.49% increase in their position. The disclosure for this purchase is available in the SEC filing. Over the last 90 days, insiders have purchased 34,155 shares of company stock worth $1,461,276. 0.54% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the company. National Pension Service boosted its position in Amrize by 7.5% during the 2nd quarter. National Pension Service now owns 1,493,022 shares of the company’s stock valued at $79,578,000 after buying an additional 103,962 shares during the period. Ancora Advisors LLC increased its position in shares of Amrize by 22.9% in the second quarter. Ancora Advisors LLC now owns 283,522 shares of the company’s stock valued at $15,112,000 after acquiring an additional 52,759 shares during the period. Engle Capital Management L.P. purchased a new position in shares of Amrize in the first quarter valued at about $3,742,000. Renaissance Technologies LLC increased its position in shares of Amrize by 10.4% in the first quarter. Renaissance Technologies LLC now owns 1,956,600 shares of the company’s stock valued at $109,609,000 after acquiring an additional 183,900 shares during the period. Finally, Punch & Associates Investment Management Inc. bought a new position in shares of Amrize during the first quarter valued at about $8,864,000.

About Amrize

(Get Free Report)

Amrize is a North American building materials and construction solutions company serving customers across the United States and Canada. Its operations span the construction materials and building envelope markets. The company supplies cement, aggregates, ready-mix concrete and asphalt, as well as roofing and other building-envelope products and services. These materials and solutions support residential, commercial and infrastructure projects. Amrize became an independent publicly traded company in 2025 through the spin-off of Holcim’s North American business.

Further Reading

Analyst Recommendations for Amrize (NYSE:AMRZ)

Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.